Sheng Chen
ORCID:0009-0003-4845-1513
发表论文 45 篇 · 总被引 11 次 · h-index 1
代表论文
- A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity (2024 · Molecular Cancer Therapeutics · 被引 9)
- Reduced cytomegalovirus reactivation and viremia following unrelated donor peripheral blood stem cell transplantation (URD-PBSCT) with targeted anti-thymocyte globulin (ATG) dosing: A prospective study (2025 · Cancer Pathogenesis and Therapy · 被引 1)
- Patients Beyond the Optimal Range of rATG-AUC Still Benefit from the Targeted Dosing Strategy in Unmanipulated Haplo-PBSCT (2024 · Transplantation and Cellular Therapy · 被引 1)
- Figure S5 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity (2026)
- Figure S3 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity (2026)
- Figure S2 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity (2026)